Back to search results

Digoxin In NASH (CODIN)

Abroad (travel likely)RecruitingPHASE2

Conditions

NASH · NAFLD · MASH - Metabolic Dysfunction-Associated Steatohepatitis · Mash · MASH With Fibrosis · MASLD · Fatty Liver Disease · Fatty Liver Disease, Nonalcoholic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Yale New Haven Health, New Haven, Connecticut, United States

    Contact: Study coordinator (Bubu Banini, MD) · bubu.banini@yale.edu
    Contact: Study coordinator (Aida Rodriguez Murillo) · aida.rodriguezmurillo@yale.edu
    Contact: Principal Investigator (Bubu Banini, MD)

  • Yale New Haven Hospital, New Haven, Connecticut, United States

    Contact: Study coordinator (Bubu Banini, MD) · bubu.banini@yale.edu
    Contact: Study coordinator (Aida Rodriguez Murillo) · aida.rodriguezmurillo@yale.edu
    Contact: Principal Investigator (Bubu Banini, MD)
Study leads

  • Bubu A Banini, MD, PhD

    Principal Investigator

    Yale University

View source on ClinicalTrials.gov(opens in a new tab)